tesaglitazar has been researched along with pregna-4,17-diene-3,16-dione, (17z)-isomer in 1 studies
Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (pregna-4,17-diene-3,16-dione, (17z)-isomer) | Trials (pregna-4,17-diene-3,16-dione, (17z)-isomer) | Recent Studies (post-2010) (pregna-4,17-diene-3,16-dione, (17z)-isomer) |
---|---|---|---|---|---|
74 | 13 | 25 | 15 | 0 | 8 |
Protein | Taxonomy | tesaglitazar (IC50) | pregna-4,17-diene-3,16-dione, (17z)-isomer (IC50) |
---|---|---|---|
Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | 0.0024 | |
Glucocorticoid receptor | Homo sapiens (human) | 6.06 | |
Progesterone receptor | Homo sapiens (human) | 0.74 | |
Mineralocorticoid receptor | Homo sapiens (human) | 1.88 | |
Androgen receptor | Homo sapiens (human) | 0.66 | |
Bile acid receptor | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chander, R; Chaturvedi, D; Ray, S; Srivastava, AK | 1 |
1 other study(ies) available for tesaglitazar and pregna-4,17-diene-3,16-dione, (17z)-isomer
Article | Year |
---|---|
Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents.
Topics: Alkanes; Alkylation; Amination; Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Molecular Structure; Naphthalenes; PPAR gamma; Rats; Structure-Activity Relationship | 2008 |